Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Tocqueville Asset Management L.P.

Tocqueville Asset Management L.P. decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 24,777 shares of the medical equipment provider’s stock after selling 36 shares during the quarter. Tocqueville Asset Management L.P.’s holdings in Intuitive Surgical were worth $12,933,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the stock. Bennett Selby Investments LP increased its holdings in Intuitive Surgical by 3.9% in the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after buying an additional 17 shares in the last quarter. Onefund LLC increased its stake in Intuitive Surgical by 1.9% in the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock valued at $494,000 after purchasing an additional 18 shares in the last quarter. LVW Advisors LLC raised its holdings in Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after purchasing an additional 19 shares during the last quarter. Wesbanco Bank Inc. boosted its position in Intuitive Surgical by 1.6% during the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after purchasing an additional 19 shares in the last quarter. Finally, Journey Strategic Wealth LLC grew its holdings in Intuitive Surgical by 1.9% in the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock valued at $542,000 after purchasing an additional 19 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now owns 5,758 shares of the company’s stock, valued at approximately $2,793,033.06. This represents a 60.72 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.90% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on ISRG. Evercore ISI lifted their price target on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Stifel Nicolaus lifted their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Raymond James lifted their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Finally, Royal Bank of Canada increased their target price on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $610.19.

Intuitive Surgical Stock Up 0.9 %

Shares of ISRG opened at $488.80 on Tuesday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The company’s fifty day moving average is $566.38 and its two-hundred day moving average is $531.96. The firm has a market cap of $174.10 billion, a PE ratio of 76.26, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.